Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...

Alumis is also developing another tyrosine kinase 2 blocker, A-005, for neuroinflammatory and neurodegenerative conditions ...

Lack of pain Ischemic optic neuropathy, NMO-associated optic neuritis, LHON, Susac syndrome, various maculopathies Disc hemorrhages Ischemic optic neuropathy, inflammatory optic neuritis ...

Lupus involves unpredictable symptom flares and potential changes in brain chemistry that may increase your risk of experiencing depression and anxiety. Lupus is a chronic (long-term) autoimmune ...

July 10, 2024 — Scientists have discovered a molecular defect that promotes the pathologic immune response in systemic lupus erythematosus (known as lupus) and show that reversing this defect ...

Obinutuzumab, a humanized type II anti-CD20 monoclonal antibody, provided significantly better renal responses than placebo in a phase 2 trial involving patients with lupus nephritis receiving ...

Natural treatments for lupus are often used alongside conventional medical treatment. They may be used to help reduce symptoms, which can include fatigue, joint pain, and hair loss. Lupus is an ...